🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 22 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/02/2019 139,06 141,75 137,31 141,60 +1,40% 3,19% 732.300
01/02/2019 140,00 140,47 135,03 139,65 -0,04% 3,89% 1.404.500
31/01/2019 130,72 139,89 130,40 139,71 +7,53% 7,26% 2.353.700
30/01/2019 118,27 130,00 117,75 129,93 +12,19% 10,36% 1.782.700
29/01/2019 116,36 116,83 113,96 115,81 -0,19% 2,47% 483.900
28/01/2019 121,51 122,38 115,90 116,03 -5,48% 5,33% 640.300
25/01/2019 122,00 122,99 119,13 122,76 +1,44% 3,16% 567.200
24/01/2019 119,34 121,07 117,63 121,02 +1,94% 2,88% 434.300
23/01/2019 121,35 123,99 117,13 118,72 -1,30% 5,65% 686.900
22/01/2019 121,84 122,53 119,15 120,28 -2,05% 2,77% 790.000
18/01/2019 122,46 123,22 120,39 122,80 +1,22% 2,31% 587.100
17/01/2019 118,35 124,41 117,49 121,32 +1,73% 5,85% 841.200
16/01/2019 118,90 121,99 117,67 119,26 +0,45% 3,63% 651.700
15/01/2019 118,48 120,49 117,11 118,73 +0,11% 2,85% 922.700
14/01/2019 119,00 121,02 118,23 118,60 -1,63% 2,34% 774.400
11/01/2019 118,90 121,88 117,50 120,57 +1,84% 3,68% 954.700
10/01/2019 114,45 119,17 113,28 118,39 +2,98% 5,15% 1.001.700
09/01/2019 111,01 116,25 110,34 114,96 +3,62% 5,32% 904.300
08/01/2019 111,57 112,04 106,51 110,94 +0,84% 4,96% 1.623.400
07/01/2019 120,00 125,43 103,68 110,02 -4,69% 18,13% 4.142.600
04/01/2019 108,20 116,22 107,37 115,43 +8,21% 8,18% 1.987.900
03/01/2019 108,06 109,74 105,22 106,67 -0,77% 4,18% 934.300
02/01/2019 107,90 109,86 105,50 107,50 -1,49% 4,04% 698.200
31/12/2018 108,79 110,73 108,00 109,13 +1,18% 2,51% 860.800
28/12/2018 108,12 110,29 105,53 107,86 +0,29% 4,40% 757.900
27/12/2018 105,01 108,50 101,79 107,55 +1,40% 6,39% 999.900
26/12/2018 98,19 106,12 98,19 106,07 +8,99% 8,08% 837.500
24/12/2018 96,63 100,68 95,21 97,32 -1,20% 5,66% 525.200
21/12/2018 102,66 102,66 96,23 98,50 -3,23% 6,26% 1.447.800
20/12/2018 106,01 107,18 96,60 101,79 -1,28% 9,98% 1.511.300